TABLE 1.
Varicella Vaccine Recipients (n = 16 075) | Hepatitis A Vaccine Recipients (n = 594 917) | Hepatitis B Vaccine Recipients (n = 590 445) | |
Site, % | |||
1 | 6 | 6 | 6 |
2 | 51 | 55 | 45 |
3 | 6 | 4 | 6 |
4 | 3 | < 1 | 4 |
5 | 1 | < 1 | 3 |
6 | 1 | < 1 | 1 |
7 | 32 | 35 | 35 |
Age, % | |||
2–4 y | 27 | ||
5–8 y | 15 | 15 | |
9–12 y | 19 | 44 | |
13–17 y | 73 | 17 | 26 |
18–29 y | 13 | 4 | 4 |
30–49 y | 14 | 8 | 7 |
50–64 y | 7 | 3 | |
≥ 65 y | 3 | 1 | |
Male, % | 46 | 49 | 49 |
Years of continuous enrollment during study period, mean (range) | |||
Before first dose | 4.5 (1.0–11.9) | 4.8 (1.0–12.0) | 4.4 (1.0–12.0) |
After first dose | 4.2 (2.0–9.2) | 3.8 (2.0–9.3) | 5.1 (2.0–9.3) |
Total | 8.7 (3.0–14.1) | 8.6 (3.0–14.1) | 9.5 (3.0–14.1) |
Year when first dose was received, % | |||
1996 | 13 | 2 | 15 |
1997 | 15 | 4 | 22 |
1998 | 17 | 5 | 22 |
1999 | 17 | 6 | 19 |
2000 | 14 | 28 | 10 |
2001 | 13 | 30 | 7 |
2002 | 11 | 25 | 5 |
Any chronic condition, % | 7 | 9 | 7 |
No. of medical visits in year prior to first dose | |||
0 | 55 | 49 | 57 |
1–10 | 42 | 48 | 41 |
> 10 | 3 | 3 | 2 |